SEC Form 4 · accession 0001104659-18-045068
Jaguar Health, Inc. · JAGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Greg J Divis
Director
Period of report
Jul 11, 2018
Accepted (ET)
Jul 13, 2018 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001585608
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2,F3 | $1.36 | Jul 11, 2018 | A | 104,860 | A | — | Jul 11, 2028 | Common Stock | 104,860 | 104,860 | D |
Explanation of responses
- F1Granted pursuant to the Issuer's 2014 Equity Incentive Plan.
- F2The option grant was approved by the Issuer's board of directors on July 11, 2018.
- F3Vests in equal monthly installments, beginning on July 11, 2018, such that it is vested in full on the 3-year anniversary of the grant date.